1. Home
  2. BZ vs HALO Comparison

BZ vs HALO Comparison

Compare BZ & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BZ

KANZHUN LIMITED American Depository Shares

HOLD

Current Price

$21.09

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.77

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZ
HALO
Founded
2013
1998
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
7.4B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BZ
HALO
Price
$21.09
$68.77
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$26.00
$73.33
AVG Volume (30 Days)
2.4M
2.3M
Earning Date
11-18-2025
11-03-2025
Dividend Yield
0.80%
N/A
EPS Growth
69.83
56.68
EPS
0.77
4.74
Revenue
$1,125,491,208.00
$1,242,852,000.00
Revenue This Year
$15.60
$34.83
Revenue Next Year
$13.18
$24.84
P/E Ratio
$27.40
$14.54
Revenue Growth
12.66
31.19
52 Week Low
$12.85
$47.00
52 Week High
$25.26
$79.50

Technical Indicators

Market Signals
Indicator
BZ
HALO
Relative Strength Index (RSI) 50.09 58.75
Support Level $20.82 $61.23
Resistance Level $21.66 $69.28
Average True Range (ATR) 0.56 1.69
MACD 0.07 0.69
Stochastic Oscillator 68.02 93.54

Price Performance

Historical Comparison
BZ
HALO

About BZ KANZHUN LIMITED American Depository Shares

Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: